Search hospitals
>
Nebraska
>
Omaha
University of Nebraska Medical Center
Claim this profile
Omaha, Nebraska 68105
Global Leader in Cancer
Global Leader in Lymphoma
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Leukemia
1232 reported clinical trials
94 medical researchers
Summary
University of Nebraska Medical Center is a medical facility located in Omaha, Nebraska. This center is recognized for care of Cancer, Lymphoma, Lung Cancer, Breast Cancer, Leukemia and other specialties. University of Nebraska Medical Center is involved with conducting 1,232 clinical trials across 1,408 conditions. There are 94 research doctors associated with this hospital, such as Jill C. Beck, Minnie Abromowitch, Jonathan Thompson, MD, and Matthew Lunning, DO.
Area of expertise
Cancer
University of Nebraska Medical Center has run 167 trials for Cancer. Some of their research focus areas include:
Lymphoma
University of Nebraska Medical Center has run 105 trials for Lymphoma. Some of their research focus areas include:
Top PIs
Jill C. Beck
Children's Hospital and Medical Center of Omaha
6 years of reported clinical research
Minnie Abromowitch
Children's Hospital and Medical Center of Omaha
8 years of reported clinical research
Jonathan Thompson, MD
Medical College of Wisconsin
5 years of reported clinical research
Matthew Lunning, DO
University of Nebraska Medical Center
8 years of reported clinical research
Clinical Trials running at University of Nebraska Medical Center
Cancer
Skin Cancer
Lung Cancer
Breast Cancer
Breast cancer
Prostate Cancer
Cervical Cancer
Testicular cancer
Brain Tumor
Multiple Myeloma
CCS1477
for Blood Cancers
A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin Lymphoma, Multiple Myeloma, Acute Myeloid Leukaemia or High Risk Myelodysplastic syndrome.
Recruiting
3 awards
Phase 1 & 2
5 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting
2 awards
Phase 3
26 criteria
Immunotherapy + Chemotherapy
for Sarcoma
This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.
Recruiting
2 awards
Phase 3
10 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Nebraska Medical Center?
University of Nebraska Medical Center is a medical facility located in Omaha, Nebraska. This center is recognized for care of Cancer, Lymphoma, Lung Cancer, Breast Cancer, Leukemia and other specialties. University of Nebraska Medical Center is involved with conducting 1,232 clinical trials across 1,408 conditions. There are 94 research doctors associated with this hospital, such as Jill C. Beck, Minnie Abromowitch, Jonathan Thompson, MD, and Matthew Lunning, DO.
Where is University of Nebraska Medical Center located?
The University of Nebraska Medical Center (UNMC) is located at 4400 Emile St, Omaha, NE 68105. It is part of a campus that includes multiple buildings and clinics. For specific departments, please contact them directly or call UNMC Mail Services at (402) 559-5315.
Who should I call to ask about financial aid or insurance network?
**University of Nebraska Medical Center Hospital Financial Assistance and Insurance Information:** - **Billing and Insurance Inquiries:** Visit the Munroe-Meyer Institute's Billing and Insurance page for details on billing through Nebraska Medicine and insurance coverage verification before appointments. - **Financial Assistance:** For information on financial assistance options, including application forms and summaries in various languages, visit the Financial Assistance page on the Nebraska Medicine website. Contact a Patient Financial Counselor at 402.559.5346 or pasfinancialcounselors@nebraskamed.com, available Monday through Friday, 6:30 a.m. to 5 p.m. - **General Billing Questions:** Reach out to Patient Financial Services at 402.559.3140 or 888.662.8662, or visit the walk-in locations as listed on the Nebraska Medicine website.
What insurance does University of Nebraska Medical Center accept?
The University of Nebraska Medical Center mandates the United Healthcare Student Insurance plan for specific student groups, including those enrolled in 12 or more credit hours, undergraduate and graduate nursing students, graduate students in nine or more credit hours, doctorate students in PhD programs, and MMI visiting scholars. Other students may opt into this plan, which covers medical, dental, and prescription needs. For patient care, the University of Nebraska Medical Center accepts a wide range of insurance plans, including but not limited to Aetna Healthcare, Blue Cross Blue Shield of Nebraska, Medicaid, Medicare, and UnitedHealthcare for general medical coverage; Aetna Behavioral Health and Tricare West for behavioral health; Ameritas Dental and Delta Dental for dental coverage; and Aetna Institutes of Excellence for transplant services. Vision coverage is provided through Avesis and EyeMed. Patients are advised to verify their benefits and coverage with their insurance company before seeking care.
What awards or recognition has University of Nebraska Medical Center received?
The University of Nebraska Medical Center (UNMC) hospital in Omaha, Nebraska, is recognized as the top-rated hospital in Nebraska for nine consecutive years by U.S. News & World Report. It has earned multiple accolades, including the National Consumer Choice Award for 13 consecutive years, Becker's Hospital Review Top 100 Hospital for seven consecutive years, Magnet Designation from the American Nurses Credentialing Center, and the Health Equality Index Top Performer recognition from the Human Rights Campaign. The Nebraska Biocontainment Unit, a joint project with Nebraska Medicine, has been honored with awards from the White House and the Nebraska Legislature for its exceptional care.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.